---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-282988"
form_type: "8-K"
ticker: "HRTX"
cik: "0000818033"
company_name: "HERON THERAPEUTICS, INC. /DE/"
filed_at: "2026-06-25T21:00:14+00:00"
generated_at: "2026-06-25T21:03:21.314549+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Heron Therapeutics receives Nasdaq notice for bid price below $1.00; 180 days to cure

## Summary
- On June 25, 2026, Nasdaq notified Heron that its common stock closing bid price was below $1.00 for 30 consecutive trading days (May 12–June 24, 2026).
- Company has 180 calendar days, until December 22, 2026, to regain compliance by maintaining bid price ≥ $1.00 for at least 10 consecutive days.
- If not cured, Heron may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.
- There is no immediate impact on trading; shares continue to trade under HRTX on Nasdaq Capital Market.
- Company intends to monitor share price and explore options to regain compliance.

## SEC filing metadata
- accession: 0001193125-26-282988
- form_type: 8-K
- ticker: HRTX
- cik: 0000818033
- company_name: HERON THERAPEUTICS, INC. /DE/
- filed_at: 2026-06-25T21:00:14+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818033/000119312526282988/0001193125-26-282988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818033/000119312526282988/hrtx-20260625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-282988
- JSON: https://secwatch.observer/filing/0001193125-26-282988.json
- Plain text: https://secwatch.observer/filing/0001193125-26-282988.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.